Benzinga's Top #PreMarket Losers

EDAP TMS SA EDAP fell 39.47% to $2.07 in pre-market trading following the FDA Panel rejection of Ablatherm-HIFU for the treatment of prostate cancer. QuickLogic QUIK dropped 23.40% to $3.24 in pre-market trading after the company reported a Q2 loss of $0.04 per share on revenue of $6.80 million. Grifols SA GRFS shares declined 9.80% to $38.10 in pre-market trading after falling 0.07% on Wednesday. Glu Mobile GLUU dipped 7.97% to $6.35 in pre-market trading after the company reported a Q2 loss of $0.02 per share on revenue of $40.90 million. Benchmark downgraded Glu Mobile from Buy to Hold.